Two cases of multiple myeloma, presenting with light-chain tubulopathy
Light chain only variant of proliferative glomerulonephritis with monoclonal immunoglobulin deposits is associated with a high detection rate of the pathogenic plasma cell clone - Kidney International
The role of bone marrow biopsy in patients with plasma cell disorders: should all patients with a monoclonal protein be biopsied? | Blood Cancer Journal
All About Multiple Myeloma Test and Result Interpretations
Serum free light chain levels and renal function at diagnosis in patients with multiple myeloma | BMC Nephrology | Full Text
PLOS ONE: Abnormal IGF-Binding Protein Profile in the Bone Marrow of Multiple Myeloma Patients
Follow-up of IgD-κ multiple myeloma by monitoring free light chains and total heavy chain IgD: A case report
Types of Multiple Myeloma | International Myeloma Foundation
MULTIPLE MYELOMA AND LIGHT-CHAIN AMYLOIDOSIS: A RARE PRESENTATION
Comparison of medians of serum levels of involved HLC to the stage 1-3... | Download Scientific Diagram
Frontiers | Study on the Relationship Between the Expression of B Cell Mature Antigen and the Classification, Stage, and Prognostic Factors of Multiple Myeloma | Immunology
SciELO - Brasil - Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies Serum free light chain assays not total light chain
Co-evolution of tumor and immune cells during progression of multiple myeloma | Nature Communications
Light chain multiple myeloma, clinic features, responses to therapy and survival in a long-term study | World Journal of Surgical Oncology | Full Text
Multiple Myeloma: Diagnosis and Treatment - American Family Physician
Isatuximab, carfilzomib, and dexamethasone in relapsed multiple myeloma (IKEMA): a multicentre, open-label, randomised phase 3 trial - The Lancet
Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): follow-up analysis of a randomised, phase 3 study - The Lancet Oncology
Q397-443: Multiple Myeloma / Plasma Cell Disorder - Forms Instruction Manual - 1
Kappa and Lambda Light Chains - The Myeloma Crowd
PDF) Serum free light chain levels and renal function at diagnosis in patients with multiple myeloma
Novel Prognostic Modalities in Multiple Myeloma | IntechOpen
